Blockchain Registration Transaction Record

GeoVax Labs Responds to Detection of Clade I Mpox in North Carolina Wastewater

GeoVax Labs responds to the detection of Clade I Mpox viral particles in North Carolina, emphasizing the need for expanded preparedness and vaccine availability. Learn how the company's GEO-MVA vaccine is advancing as a key U.S.-developed candidate for Mpox/smallpox.

This news underscores the urgent need for enhanced preparedness and vaccine availability in the wake of the Clade I Mpox threat. It highlights the importance of early detection systems like the Wastewater Monitoring Network and the critical role of domestic vaccine development in safeguarding against future viral outbreaks.